Comment: Economic Impacts Associated with Recombinant Bovine Somatotropin (rBST) Use

MOspace/Manakin Repository

Breadcrumbs Navigation

Comment: Economic Impacts Associated with Recombinant Bovine Somatotropin (rBST) Use

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/317

[+] show full item record


Title: Comment: Economic Impacts Associated with Recombinant Bovine Somatotropin (rBST) Use
Other Titles: Economic Impacts Associated with Recombinant Bovine Somatotropin (rBST) Use
Author: Losinger, Willard C.
Keywords: rBST
nonmilk productivity
micro-economic analysis
Date: 2002
Publisher: AgBioForum
Citation: AgBioForum, 5(1) 2002: 25-27.
Abstract: The article "Economic Impacts Associated with Recombinant Bovine Somatotropin (rBST) Use," which appeared in AgBioForum 3(2&3), merits somewhat closer scrutiny. The article was based on a pair of regression models which Ott and Rendleman (2000) had developed for herd milk production and for herd "nonmilk productivity." These regression models are quite similar to a series of models that Ott, Wells, and Wagner (1999) and Ott and Novak (2001) had created to examine economic losses associated with Johne's disease and with bulk-tank somatic cell counts, respectively. Either Ott and Novak (2001) need to retract the square root of the percent of rBST use as an explanatory variable for milk production, or Ott and Rendleman (2000) ought to reconsider the quadratic expression for the percent of rBST use in their model for milk production. Both models lead to very different conclusions about the relationship between rBST use and milk production, and both cannot be correct.
URI: http://hdl.handle.net/10355/317
ISSN: 1522-936X

This item appears in the following Collection(s)

[+] show full item record